Skip to content
Recall Observatory FDA recall evidence

Drug product

OraVerse (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a box of 10 cartridges of 0.4mg/1.7mL each, Rx only, Distributed by Septodont, Inc., Louisville, CO 80027, Made in Canada by Novocol Pharmaceutical of Canada, Inc., NDC 0362-0101-10

D-0828-2018

April 13, 2018

Class III

Product summary

Firm
Septodont Inc.
Event
Event 79976
Status
Terminated
Classification
Class III
Quantity
8509 boxes
Official record key
drug-enforcement:D-0828-2018

Official wording

Reason: Failed Impurities/Degradation: This recall has been initiated due to an out of specification (OOS) result that was obtained for related substance (Phentolamide), a known degradation product impurity at the 15 month stability test point.

Code information: Lot #'s D01894E and D01894G

Distribution pattern: USA, Italy and France

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification

Field note

Send feedback

We'll only use this to respond to your feedback.